Artificial intelligence and machine learning in precision and genomic medicine

S Quazi - Medical Oncology, 2022‏ - Springer
The advancement of precision medicine in medical care has led behind the conventional
symptom-driven treatment process by allowing early risk prediction of disease through …

Applications of machine learning in drug discovery and development

J Vamathevan, D Clark, P Czodrowski… - Nature reviews Drug …, 2019‏ - nature.com
Drug discovery and development pipelines are long, complex and depend on numerous
factors. Machine learning (ML) approaches provide a set of tools that can improve discovery …

Development of a clinical polygenic risk score assay and reporting workflow

L Hao, P Kraft, GF Berriz, ED Hynes, C Koch… - Nature medicine, 2022‏ - nature.com
Implementation of polygenic risk scores (PRS) may improve disease prevention and
management but poses several challenges: the construction of clinically valid assays …

Data-driven strategies for accelerated materials design

R Pollice, G dos Passos Gomes… - Accounts of Chemical …, 2021‏ - ACS Publications
Conspectus The ongoing revolution of the natural sciences by the advent of machine
learning and artificial intelligence sparked significant interest in the material science …

Toxicity testing in the 21st century: progress in the past decade and future perspectives

D Krewski, ME Andersen, MG Tyshenko… - Archives of …, 2020‏ - Springer
Advances in the biological sciences have led to an ongoing paradigm shift in toxicity testing
based on expanded application of high-throughput in vitro screening and in silico methods …

Virtual microdissection identifies distinct tumor-and stroma-specific subtypes of pancreatic ductal adenocarcinoma

RA Moffitt, R Marayati, EL Flate, KE Volmar… - Nature …, 2015‏ - nature.com
Pancreatic ductal adenocarcinoma (PDAC) remains a lethal disease with a 5-year survival
rate of 4%. A key hallmark of PDAC is extensive stromal involvement, which makes …

Radiomics in nuclear medicine: robustness, reproducibility, standardization, and how to avoid data analysis traps and replication crisis

A Zwanenburg - European journal of nuclear medicine and molecular …, 2019‏ - Springer
Radiomics in nuclear medicine is rapidly expanding. Reproducibility of radiomics studies in
multicentre settings is an important criterion for clinical translation. We therefore performed a …

[HTML][HTML] CD8 T cell score as a prognostic biomarker for triple negative breast cancer

M Oshi, M Asaoka, Y Tokumaru, L Yan… - International journal of …, 2020‏ - mdpi.com
CD8 T cell is an essential component of tumor-infiltrating lymphocytes (TIL) and tumor
immune microenvironment (TIME). Using the xCell CD8 T cell score of whole tumor gene …

Blood molecular markers associated with COVID‐19 immunopathology and multi‐organ damage

YM Chen, Y Zheng, Y Yu, Y Wang, Q Huang… - The EMBO …, 2020‏ - embopress.org
COVID‐19 is characterized by dysregulated immune responses, metabolic dysfunction and
adverse effects on the function of multiple organs. To understand host responses to COVID …

Clinical drug response can be predicted using baseline gene expression levels and in vitrodrug sensitivity in cell lines

P Geeleher, NJ Cox, RS Huang - Genome biology, 2014‏ - Springer
We demonstrate a method for the prediction of chemotherapeutic response in patients using
only before-treatment baseline tumor gene expression data. First, we fitted models for whole …